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Editorial on the Research Topic
Epigenetic Mechanisms Regulating Neural Plasticity
While larger parts of the genome have been deciphered and sequenced during the last decade, it is
now possible to identify practically all the genes that a cell or tissue transcribes and translates at a
givenmoment in time (Wheeler et al., 2008). Thus, the challenge we are now facing is to understand
the epigenetic regulation of all this information, it will be the next great task in the near future. The
central nervous system (CNS), and especially the brain, has evolved to make humans the way they
are, and it is strongly influenced and affected by epigenetic factors (Stroud et al., 2017). Indeed,
many extrinsic factors can alter neural activity during the lifetime of an organism (from the embryo
to adult and during aging), including diet, exercise, environmental variations, stressors, etc. These
stimuli exert their effect through processes commonly referred to as “Epigenetic mechanisms”
(Sen et al., 2016), which mainly involve DNA methylation and demethylation, protein acetylation
and deacetylation (mainly histones) and regulatory small non-coding RNAs, primarily microRNAs
(miRNA) activity, all important events in the regulation of neuronal plasticity. Consequently,
this special issue aims to shed light on the physiological and pathological processes affected by
epigenetic mechanisms that are involved in the regulation of neural plasticity, highlighting the
potential diagnostic and therapeutic strategies that may become commonplace in the future.
Accordingly, this volume presents a collection of works, both reviews and original studies, that
address the aforementioned issues, representing the ideas of 100 researchers from eight countries
on three continents.
Epigenetic mechanisms have been proposed to strongly participate in the adaptive features of the
CNS, both those of a physiological (from embryonic development through aging) and pathological
(from cancer to neurodegenerative conditions) nature. Changes in the epigenome allow neurons to
reorganize in response to intrinsic or extrinsic stimuli, and to develop ormaintain specific activities.
As such, the study of epigenetics is potentially interesting when attempting to develop strategies
that modulate changes provoked in pathological conditions, particularly since extrinsic factors and
pharmacological tools can modify neural function in an organism throughout its life. Therefore,
diet, exercise, environmental conditions, stressors or drugs can alter pathological events to benefit
the patient, driving epigenetic processes that co-ordinate a number of translational processes.
Post-translational modifications have been implicated in neurological pathologies like
Parkinson’s disease (PD), including protein acetylation. In fact, when acetylated proteins and
peptides were characterized in primary fibroblasts from patients with inherited and idiopathic PD,
differences were described in the hyperacetylated and hypoacetylated peptides between the two
pathological entities (see Yakhine-Diop et al.). Additionally, acetyl-CoA metabolism is relevant in
regulating multiple protein acetylation reactions in the brain, which in turn regulate the functional
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and adaptative properties of brain cells (both neuronal and
non-neuronal). Ronowska et al. highlights the importance
of the changes in intraneuronal acetyl-CoA and its
compartmentalization, which contributes to the development of
different neurodegenerative brain disorders.
Epigenetic elements or tags can be read (recognized), written
(established), and erased (removed) in nucleosomes, mainly
through DNA methylation and demethylation. The influence
of demethylation in the adult brain and on neurological
disorders, as well as its possible functional consequences for
health and disease, has been reviewed by Bayraktar and Kreutz.
Similarly, a key role for epigenetic DNA modifications has been
identified by Andrés-Benito et al. demonstrating a decrease in the
methylation of the Katanin Interactor Protein gene (KIAA0566)
in associationwith age and the presence of neurofibrillary tangles,
the main pathological characteristics of taupathies. Indeed,
this particular alteration in DNA methylation has important
implications for the regulation of microtubule homeostasis in
locus coeruleus neurons. The review by Penas and Navarro
focuses on the implication of a wider set of epigenetic changes
that appear to trigger modifications in nociception after neural
lesions, including histone modifications, DNA methylation,
the expression of non-coding RNAs and altered chromatin
modifier activity. As such, novel putative targets to manage
neuropathic pain are proposed, which remains an unmet clinical
need, such as histone deacetylases (HDAC1, Sirt1), histone
demethylases (JMJD3), histone methyltransferases (G9a, EZH2),
DNA methyltransferase (DNMT3b), transcriptional repressor
complex (REST), Methyl CpG binding protein (MeCP2), and
various non-coding RNAs. The correct delivery of microRNAs
is a key factor for their possible therapeutic application and
Reza-Zaldivar et al. explain why exosomes could constitute
an adequate vehicle for the delivery of microRNAs in
biological systems, for example, as an alternative treatment for
Alzheimer’s disease.
In addition to the aforementioned epigenetic mechanisms,
stress, changes in diet and the environment, or even situations
of extreme environments like outer space, can influence
neuroplasticity and consequently, affect the activity of the CNS.
In this respect, Herrera et al. demonstrate that controlling
dietary long-chain polyunsaturated fatty acid (L-CPFA) content
modulates the expression of synaptogenesis-related neuronal
proteins, in conjunction with the influence of hormones. Indeed,
estradiol and progesterone levels, as well as cyclic ovarian
secretory activity, may modulate the effects of dietary L-CPFA
in cerebral cortex physiology, which for example, may have
clinical implications for postmenopausal women. In addition,
Benoit et al. show how nutrient variations and hormonal
changes early in development can reprogram metabolism
in adulthood. Specifically, they demonstrate the changes in
expression of eleven microRNAs induced by hyperinsulinemia
and/or hyperleptinemia in the arcuate nucleus, a master regulator
of energy homeostasis. This reveals how an altered perinatal
environment can affect metabolism in adulthood.
With respect to the importance of the environment on
genomic expression, Griñán-Ferré et al. demonstrate how
significant improvements in brain function and cognitive abilities
can be achieved in a model of aging through interventions
that involve environmental enrichment. Importantly, these
authors demonstrate that epigenetic mechanisms at least in part
drive some of the beneficial effects of environmental enrichment,
such as the decreased neuroinflammation and enhanced
synaptic function. As described previously, environmental
enrichment increases the cognitive reserve in humans,
helping combat the deleterious effects of neurodegeneration
(Redolat and Mesa-Gresa, 2012). Hence, the individual’s
physical and social surroundings are clearly important in
providing the brain with some arms to resist neurodegenerative
processes, increasing resilience of paramount importance in
aging processes.
By contrast, the work by Muñoz-Llanos et al. focuses on the
effect of chronic stress on synaptic plasticity in the hippocampus,
giving importance to the effect of epigenetic mechanisms on
learning and memory processes. They identified miRNA-92a
and miR-485 as potential targets to produce changes in gene
regulatory networks within the hippocampus of stressed rats,
modifying the dynamics of neuroplasticity. As such, these non-
coding regulatory RNAs could represent novel targets for the
treatment of depression.
Finally, Cui et al. present a detailed genomic analysis of the
differentiation of neuronal stem cells (NSCs) in outer space
flights. During such spaceflight experimental conditions, NSCs
maintain a greater capacity for stemness even though their
growth rate slows down. This type of study will help us begin
to understand the possible physiological changes in the CNS
associated with future space travel.
In conjunction, in this volume breakthrough new information
is collected regarding the cellular and molecular mechanisms
underlying synaptic plasticity in neurodegenerative diseases like
Parkinson’s, or Alzheimer’s, as well as in other CNS disorders
like depression or neuropathic pain. In addition, further valuable
information is provided regarding the physiology of the brain, all
from the perspective of epigenetic regulation.
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